178 related articles for article (PubMed ID: 15553738)
1. [Safety of intraperitoneal chemotherapy with paclitaxel in gastric cancer patients with peritoneal dissemination].
Fujitani K; Hirao M; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1855-7. PubMed ID: 15553738
[TBL] [Abstract][Full Text] [Related]
2. [A case of recurrent gastric cancer with malignant ascites responding dramatically to chemotherapy with paclitaxel infused systemically and intraperitoneally].
Morifuji M; Murakami Y; Yokoyama Y; Sasaki M; Hayashidani Y; Toge K; Sueda T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2027-30. PubMed ID: 15570933
[TBL] [Abstract][Full Text] [Related]
3. [A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].
Kato K; Koide A; Oobu M; Hasegawa K; Maruyama S; Takashima I; Nagahama T; Maruyama M; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1852-4. PubMed ID: 15553737
[TBL] [Abstract][Full Text] [Related]
4. [A phase I study of intraperitoneal plus intravenous paclitaxel against gastric cancer with peritoneal dissemination (HGCG 0301)].
Shinohara H; Okamoto S; Nishitai R; Shirakata Y; Itoi K; Yamagami K; Taki Y; Yamamoto M; Mizuno Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2027-31. PubMed ID: 17197747
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N
Gan To Kagaku Ryoho; 2004 May; 31(5):759-61. PubMed ID: 15170988
[TBL] [Abstract][Full Text] [Related]
6. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
7. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination].
Fushida S; Furui N; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2164-7. PubMed ID: 12484028
[TBL] [Abstract][Full Text] [Related]
9. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
[TBL] [Abstract][Full Text] [Related]
10. [A case responding to weekly paclitaxel (TXL) therapy as third line chemotherapy for scirrhous type gastric cancer].
Sagawa T; Tsuji Y; Takayanagi N; Hirayama Y; Sakamaki S; Chiba H; Nakajima T; Iyama S; Oku T; Sumiyoshi T; Sato Y; Takahashi M; Takayama T; Niitsu Y
Gan To Kagaku Ryoho; 2003 May; 30(5):707-10. PubMed ID: 12795107
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
Kuriyama H; Nonaka T; Sawatari T; Tsuboi H; Akanuma M; Hata Y
Gan To Kagaku Ryoho; 2005 May; 32(5):663-5. PubMed ID: 15918568
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
Kodera Y; Ito Y; Ito S; Ohashi N; Mochizuki Y; Yamamura Y; Koike M; Fujiwara M; Nakanishi H; Nakao A
Hepatogastroenterology; 2007; 54(75):960-3. PubMed ID: 17591103
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer].
Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1691-4. PubMed ID: 16315911
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
[TBL] [Abstract][Full Text] [Related]
16. [Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
Ishida T; Shimokawa H; Kawaguchi K; Nose N; Ikegami T; Itoh H; Kido A; Sasaki Y; Ezaki T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1643-6. PubMed ID: 12355953
[TBL] [Abstract][Full Text] [Related]
17. [Weekly paclitaxel therapy is useful for gastric carcinoma as second-line chemotherapy].
Mizuiri H; Yoshida K; Shimizu K; Tanabe K; Taomoto J; Suzuki T; Wada Y; Hihara J
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2043-6. PubMed ID: 15570937
[TBL] [Abstract][Full Text] [Related]
18. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
[TBL] [Abstract][Full Text] [Related]
19. [A case of intraperitoneal paclitaxel administration in a gastric cancer patient with severely impaired renal function].
Ohbu M; Maruyama M; Miyawaki Y; Tamura N; Koide A; Hasegawa K; Maruyama S; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1745-7. PubMed ID: 16315928
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
